GlassScriptPhysician profile
Derek Haight
NPI 1588028401
$77,827.33
in general payments reported to CMS, 2019-2025
29 companies · $32K in 2025
The $32K reported for 2025 was more than what 98% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $624 · 2021: $449 · 2022: $5,651 · 2023: $7,555 · 2024: $32K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $8,457 · Education: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,187.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,275.00 |
| Travel and Lodging | $11,683.86 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,250.00 |
| Food and Beverage | $8,456.64 |
| Education | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $23,590.33 | 2021-2024 | Vyrsa V1, Senza |
| Globus Medical, INC. | $22,282.91 | 2025 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $17,096.92 | 2020-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Spinal Simplicity, LLC | $5,397.49 | 2022-2024 | Ha Minuteman G3-R |
| Interventional Pain Technologies INC. | $4,000.00 | 2023 | Vyrsa V1 |
| Relievant Medsystems, INC. | $1,309.20 | 2022-2023 | Intracept |
| Abbott Laboratories | $753.68 | 2021-2024 | Proclaim, Eterna |
| Stratus Medical, LLC | $710.76 | 2022-2023 | Nimbus |
| Mml US, INC. | $519.22 | 2024-2025 | Reactiv8 |
| Abbvie INC. | $491.79 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $458.34 | 2021-2025 | Belbuca, Xtampza |
| Biotronik Nro, INC. | $293.69 | 2025 | Prospera |
| Medtronic USA, INC. | $257.51 | 2020 | |
| Medtronic, INC. | $164.36 | 2021-2025 | Inceptiv |
| Merz Pharmaceuticals, LLC | $62.97 | 2025 | Xeomin |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.65 | 2020-2022 | |
| Spr Therapeutics, INC | $50.40 | 2024-2025 | Sprint Pns System |
| Vertos Medical, INC. | $46.95 | 2021-2024 | Mild Device Kit |
| Averitas Pharma INC. | $43.46 | 2023-2024 | Qutenza |
| Saluda Medical Americas, INC. | $39.05 | 2021-2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.31 | 2024-2025 | Relistor |
| Hydrocision, INC. | $26.89 | 2025 | Tenjet |
| Si-Bone, INC. | $25.88 | 2022 | |
| Inspire Medical Systems, INC. | $25.37 | 2025 | Inspire |
| Becton, Dickinson and Company | $25.00 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $17.70 | 2025 | |
| Acacia Pharma INC | $16.20 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.00 | 2023 | Seglentis |
| Axsome Therapeutics, INC. | $14.30 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Haight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.